Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Press/Media
Datasets
Activities
Fellowships, Honors, and Prizes
Search by expertise, name or affiliation
The infectious complications of chronic lymphocytic leukemia
V. A. Morrison
Research output
:
Contribution to journal
›
Review article
›
peer-review
97
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'The infectious complications of chronic lymphocytic leukemia'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Alkylating Agents
33%
Aspergillus
33%
Candida
33%
Chemotherapy
33%
Chronic Lymphocytic Leukemia
100%
Clinical Course
33%
Common Knowledge
33%
Disease Process
33%
Disease Therapy
33%
Escherichia Coli
33%
Fludarabine
33%
Haemophilus Influenzae
33%
Herpesvirus
33%
Hypogammaglobulinemia
33%
Immune Defect
100%
Immune Function
33%
Infection Risk
66%
Infectious Complications
100%
Klebsiella Pneumoniae (K. pneumoniae)
33%
Listeria
33%
Mucosal Immune Response
33%
Mucosal Sites
33%
Mycobacterium Tuberculosis (M. tb)
33%
Nocardia
33%
Opportunistic Infections
33%
Pathogenesis of Infection
33%
Pneumocystis
33%
Population Information
33%
Primary Disease
33%
Prophylactic Treatment
33%
Pseudomonas Aeruginosa (P. aeruginosa)
33%
Purine Analogues
33%
Respiratory Tract
33%
Staphylococcus Aureus
33%
Streptococcus Pneumoniae
33%
Supportive Care
33%
Systemic Immune Response
33%
Therapeutic Approaches
33%
Therapeutic Intervention
33%
Therapy-related
33%
Pharmacology, Toxicology and Pharmaceutical Science
Alkylating Agent
20%
Aspergillus
20%
Candida
20%
Chemotherapy
20%
Chronic Lymphatic Leukemia
100%
Disease
40%
Disease Course
20%
Escherichia coli
20%
Fludarabine
20%
Haemophilus influenzae
20%
Herpesviridae
20%
Immune Deficiency
60%
Immunoglobulin Deficiency
20%
Infection
100%
Infectious Complication
100%
Klebsiella pneumoniae
20%
Listeria
20%
Mycobacterium Tuberculosis
20%
Nocardia
20%
Opportunistic Infection
20%
Pneumocystis
20%
Pseudomonas aeruginosa
20%
Purine
20%
Purine Derivative
20%
Respiratory Tract
20%
Staphylococcus Aureus
20%
Streptococcus
20%
Medicine and Dentistry
Alkylating Antineoplastic Agent
20%
Aspergillus
20%
B-Cell Chronic Lymphocytic Leukemia
100%
Chemotherapy
20%
Disease
20%
Disease Course
20%
Disease Process
20%
Escherichia coli
20%
Fludarabine
20%
Haemophilus influenzae
20%
Herpesviridae
20%
Hypogammaglobulinemia
20%
Immune Deficiency
60%
Immune Function
40%
Infection
100%
Infectious Complication
100%
Klebsiella pneumoniae
20%
Listeria
20%
Mycobacterium Tuberculosis
20%
Nocardia
20%
Opportunistic Infection
20%
Pneumococcus
20%
Pseudomonas aeruginosa
20%
Purine
20%
Staphylococcus Aureus
20%
Supportive Care
20%
Immunology and Microbiology
Aspergillus
33%
Candida
33%
Escherichia coli
33%
Haemophilus influenzae
33%
Herpesviridae
33%
Hypogammaglobulinemia
33%
Immunity
66%
Immunodeficiency
100%
Klebsiella pneumoniae
33%
Listeria
33%
Mycobacterium Tuberculosis
33%
Nocardia
33%
Opportunistic Infection
33%
Pneumococcus
33%
Pneumocystis
33%
Pseudomonas aeruginosa
33%
Staphylococcus Aureus
33%